Transcend owns BOL-148, a non-toxic second-generation LSD-derived molecule that mimics the therapeutic potential of LSD, without the psychedelic effects or hallucinations BetterLife Pharma Inc (… Read More… The post Press Release: BetterLife Pharma completes C$10M acquisition of LSD derivative owner Transcend Biodyanmics LLC first appeared on Cannabis Law Report.
Excerpt only …
READ MORE BELOW
Source : Press Release: BetterLife Pharma completes CM acquisition of LSD derivative owner Transcend Biodyanmics LLC
reposted by Cannabis News World